Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Two pharma service companies revamp
by Michael McCoy
June 20, 2016
| A version of this story appeared in
Volume 94, Issue 25
The contract research firm BioDuro has relaunched following its merger with Formex. Based in San Diego and operating mostly in China, BioDuro was acquired by PPD in 2009 but then reacquired by its founders last year. Following the merger with Formex, BioDuro now offers end-to-end drug discovery and development services, says CEO Cyrus K. Mirsaidi. Meanwhile, Frontage Laboratories has acquired two U.S. solid-dose drug plants from Sun Pharma. Frontage says the facilities will be the basis of a new contract development and manufacturing service called Frontida Biopharm.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter